[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] 兰平,李森茂,吴现瑞.重视结直肠癌的筛查和预防[J].中华消化外科杂志,2018,17(2):121-126.
[3] 张钊,刘胜利.KRAS基因突变与结直肠癌研究进展[J].东南大学学报(医学版),2016,35(1):154-157.
[4] 徐雪妮,潘玉琴.环状RNA的功能及其与结直肠癌发生、发展关系的研究进展[J].东南大学学报(医学版),2019,38(3):527-531.
[5] YUNG Y C,STODDARD N C,CHUN J.LPA receptor signaling:pharmacology,physiology,and pathophysiology[J].J Lipid Res,2014,55(7):1192-1214.
[6] STRACCI F,ZORZI M,GRAZZINI G.Colorectal cancer screening:tests,strategies,and perspectives[J].Front Public Health,2014,2:210.
[7] 上海国家消化系统疾病临床医学研究中心,国家消化道早癌防治中心联盟,中华医学会消化内镜学分会,等.中国早期结直肠癌筛查流程专家共识意见(2019,上海)[J].中华消化内镜杂志,2019,36(10):709-719.
[8] LIANG P S,WHEAT C L,ABHAT A,et al.Adherence to competing strategies for colorectal cancer screening over 3 years[J].Am J Gastroenterol,2016,111(1):105-114.
[9] 中华医学会消化内镜学会消化系早癌内镜诊断与诊疗协作组,中华医学会消化病学分会消化道肿癌协作组,中华医学会消化内镜学分会肠道原理,等.中国早期结直肠癌及癌前病变筛查与诊治共识(2014年,重庆)[J].中华消化内镜杂志,2015(2):69-85.
[10] MENG W,CAI S,ZHOU L,et al.Performance value of high risk factors in colorectal cancerscreening in China[J].World J Gastroenterol,2009,15(48):6111-6116.
[11] SUNG J J Y,NG S C,CHAN F K L,et al.An updated Asia Pacific Consensus Recommendations on colorectal cancer screening[J].Gut,2015,64(1):121-132.
[12] 翟爱军,翟惠虹,陈洪,等.APCS评分系统与问卷调查在体检人群结直肠癌机会性筛查中效果的比较[J].中华保健医学杂志,2018,20(3):217-219.
[13] 徐旭,孙延君,钟丽梅.深圳市宝安区人群结肠癌肿瘤发生风险评分系统的建立及其对结肠癌筛查效能的验证[J].现代医学,2017,45(5):685-688.
[14] SIMON K.Colorectal cancer development and advances in screening[J].Clin Interv Aging,2016,11:967-976.
[15] LEUNG W C,FOO D C,CHAN T T,et al.Alternatives to colonoscopy for population-wide colorectal cancer screening[J].Hong Kong Med J,2016,22(1):70-77.
[16] BRENNER H,HOFFMEISTER M,BIRKNER B,et al.Diagnostic performance of guaiac-based fecal occult blood test in routine screening:state-wide analysis from Bavaria,Germany[J].Am J Gastroenterol,2014,109(3):427-435.
[17] 赵玉洁,潘志忠.广州社区结直肠癌筛查现状[J].中华胃肠外科杂志,2017,20(11):1246-1250.
[18] ISSA I A,NOUREDDINE M.Colorectal cancer screening:an updated review of the available options[J].World J Gastroenterol,2017,23(28):5086-5096.
[19] 沈永洲,黄彦钦,朱云峰,等.定量与定性粪隐血试剂在结直肠癌筛查中的效果评价[J].中华消化杂志,2014,34(2):114-117.
[20] 翟爱军,陈洪,王贵齐,等.三种结直肠癌筛查方法比较研究[J].中国全科医学,2016,19(2):170-173.
[21] WOLF A,FONTHAM E,CHURCH T R,et al.Colorectal cancer screening for average-risk adults:2018 guideline update from the American Cancer Society[J].CA Cancer J Clin,2018,68(4):250-281.
[22] 铁宝霞,杨波,桑伟,等.粪便DNA检测在结直肠癌筛查中的研究进展[J].中国癌症防治杂志,2018,10(4):334-337.
[23] IMPERIALE T F,RANSOHOFF D F,ITZKOWITZ S H.Multitarget stool DNA testing for colorectal-cancer screening[J].N Engl J Med,2014,370(14):1287-1297.
[24] 彭晨,蒋小华,姜景蔚,等.多靶点粪便基因检测在社区结直肠癌筛查中的应用价值研究[J].中国全科医学,2017,20(25):3132-3135.
[25] IMPERIALE T F,RANSOHOFF D F,ITZKOWITZ S H.Multitarget stool DNA testing for colorectal-cancer screening[J].N Engl J Med,2014,371(2):187-188.
[26] BOSCH L,MELOTTE V,MONGERA S,et al.Multitarget stool DNA test performance in an average-risk colorectal cancer screening population[J].Am J Gastroenterol,2019,114(12):1909-1918.
[27] JOHNSON D H,KISIEL J B,BURGER K N,et al.Multitarget stool DNA test:clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening[J].Gastrointest Endosc,2017,85(3):657-665.
[28] QUINTERO E,CASTELLS A,BUJANDA L,et al.Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening[J].N Engl J Med,2012,366(8):697-706.
[29] CHOKSHI R V,HOVIS C E,HOLLANDER T,et al.Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy[J].Gastrointest Endosc,2012,75(6):1197-1203.
[30] BRENNER H,STOCK C,HOFFMEISTER M.Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality:systematic review and meta-analysis of randomised controlled trials and observational studies[J].BMJ,2014,348:g2467.
[31] SINGH H,NUGENT Z,DEMERS A A,et al.The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer[J].Gastroenterology,2010,139(4):1128-1137.
[32] ATKIN W S,EDWARDS R,KRALJ-HANS I,et al.Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer:a multicentre randomised controlled trial[J].Lancet,2010,375(9726):1624-1633.
[33] BAI Y,GAO J,ZOU D W,et al.Distribution trends of colorectal adenoma and cancer:a colonoscopy database analysis of 11,025 Chinese patients[J].J Gastroenterol Hepatol,2010,25(10):1668-1673.
[34] 黄力文,方圆,鲍萍萍,等.拓展全科医生在社区结直肠癌筛查中的作用[J].中华全科医师杂志,2018,17(6):486-489.
[35] 曹裕,张舒,邹晓平.间歇期结直肠癌的最新认识和研究进展[J].中华消化杂志,2015,35(3):210-212.
[36] PATEL S G,AHNEN D J.Prevention of interval colorectal cancers:what every clinician needs to know[J].Clin Gastroenterol Hepatol,2014,12(1):7-15.
[37] WIESZCZY P,REGULA J,KAMINSKI M F.Adenoma detection rate and risk of colorectal cancer[J].Best Pract Res Clin Gastroenterol,2017,31(4):441-446.
[38] NISHIHARA R,WU K,LOCHHEAD P,et al.Long-term colorectal-cancer incidence and mortality after lower endoscopy[J].N Engl J Med,2013,369(12):1095-1105.
[39] 孟江,张晓峰,徐肖攀,等.虚拟结肠镜联合光学结肠镜在结直肠癌筛查中的应用[J].中华消化内镜杂志,2017,34(10):752-756.
[40] 健康中国行动推进委员会.健康中国行动(2019-2030年):总体要求、重大行动及主要指标[J].中国循环杂志,2019,34(9):846-858. |
